Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- B cells in allergy
- Allergen-specific Memory B Cells (MBCs)
- Allergen-specific MBCs: IL-4 and IL-13 signaling
- Allergen-specific MBCs: pathogenic/tolerant
- Type 2-polarized MBCs
- Type 2-polarized MBCs: phenotype
- Type 2-polarized MBCs: ontogeny
- Type 2-polarized MBCs: specificity
- Type 2-polarized MBCs: fate
- MBCs: plasticity
- MBCs: cell vs population plasticity
- Vaccination, virus recall response, chronic exposure
- Type 2-polarized MBCs: plasticity
- A4RA induces allergen-specific IgG2c production
- IgG2c response: unswitched/class-switched B cells
- Harnessing MBC plasticity
- Thank you
Topics Covered
- Allergen-specific memory B cells (MBCs)
- Type 2-polarized memory B cells
- Type 2-polarized MBC phenotype, ontogeny, specificity and fate
- Memory B cells: plasticity
- Harnessing MBC plasticity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bruton, K. (2024, May 30). Memory B cells in allergy: ontogeny, phenotype and plasticity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/ULNZ4476.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Kelly Bruton has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Memory B cells in allergy: ontogeny, phenotype and plasticity
Published on May 30, 2024
23 min
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Kelly.
I'm a Postdoctoral Fellow
at Stanford University.
My research is centered
around studying
adaptive immune responses
involved in
IgE-mediated allergy.
In the second part of this talk,
I'll be discussing the role
of B cells in allergy.
And particularly, the
ontogeny, phenotype,
and plasticity of memory B cells
implicated in allergic disease.
0:26
B cells play a central
role in allergic disease.
Type I hypersensitivities,
which are reactions to
something like peanuts or
pollen are mediated by IgE,
which is a particular
antibody isotype.
IgE will bind to high-affinity
receptors located
on mast cells and basophils.
They coat the surface of
these cells so that when
the individual encounters
the antigen once again,
it will cross-link
the IgE molecules,
resulting in a rapid
cellular degranulation
and release of vasoactive
mediators that
ultimately cause the clinical
symptoms of an allergy.
1:07
In the last decade,
a central focus
has been on understanding
the features of immune memory
that are directed
towards allergens.
Here we're discussing B cells.
Allergen-specific memory B
cells are actually dominated
by IgG-expressing
cells rather than IgE.
This is in contrast to the
memory to something like
a virus for example, where
the isotype of those
memory B cells
are usually of the
same isotype that
the primary factor
antibody produced will be.
Because allergen-specific
memory B cells
are held in this IgG state,
it means that upon
re-exposure to the allergen,
it necessitates a
class switch event
so that they become
IgE expressing,
and then we'll terminally
differentiate into plasma cells.
This transient IgE state will
be IgE-expressing B cells.
It's actually short-lived
IgE plasma cells
that are produced
rather than long-lived.
The long-term capacity
for plasma cells
to persist appears
to be lesser when
the isotype that they're
secreting is IgE-expressing.
That means in the
context of allergy,
within the memory B
cell compartment,
is really where the
memory is held.
And it's those cells
that must be reactivated
in order to reinitiate
or replenish that
transient pool of
circulating IgE.